SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001104659-23-113519
Filing Date
2023-11-02
Accepted
2023-11-02 06:01:58
Documents
9

Document Format Files

Seq Description Document Type Size
1 FORM S-3 tm2329582-1_s3.htm S-3 492737
2 EXHIBIT 1.2 tm2329582d2_ex1-2.htm EX-1.2 263598
3 EXHIBIT 4.3 tm2329582d2_ex4-3.htm EX-4.3 342485
4 EXHIBIT 5.1 tm2329582d2_ex5-1.htm EX-5.1 33244
5 EXHIBIT 23.2 tm2329582d2_ex23-2.htm EX-23.2 2554
6 EX-FILING FEES tm2329582d2_ex-filingfees.htm EX-FILING FEES 40283
7 GRAPHIC tm2329582d2_ex5-1img001.jpg GRAPHIC 3758
8 GRAPHIC tm2329582d2_ex5-1img002.jpg GRAPHIC 2569
9 GRAPHIC lg_bioxcelthera-4c.jpg GRAPHIC 37767
  Complete submission text file 0001104659-23-113519.txt   1237061
Mailing Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511
Business Address 555 LONG WHARF DRIVE NEW HAVEN CT 06511 203-643-8060
BioXcel Therapeutics, Inc. (Filer) CIK: 0001720893 (see all company filings)

IRS No.: 821386754 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-275261 | Film No.: 231369806
SIC: 2834 Pharmaceutical Preparations